Dr. Colvin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Cox 5
Boston, MA 02114Phone+1 617-726-3812Fax+1 617-726-2894
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1999 - 2003
Brigham and Women's HospitalResidency, Internal Medicine, 1996 - 1999
Duke University School of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 1998 - 2025- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 4 citationsA First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers.Megan Osborn, Noah Stachulski, Haiying Sun, Johanne Blais, Vinay Kumar Venishetty
Antimicrobial Agents and Chemotherapy. 2019-06-24 - A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics ...Stephen Youngberg, Erin Brandt, Avantika Barve, Surendra Machineni, Christopher T. Jones
Journal of Drug Assessment. 2018-10-24 - 25 citationsMode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae.Charles R. Dean, David T. Barkan, Alun Bermingham, Johanne Blais, Fergal Casey
Antimicrobial Agents and Chemotherapy. 2018-09-24
Abstracts/Posters
- Northstar-3: Interim Results from a Phase 3 Study Evaluating Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Either a _0 or IVS-I-110...Richard A. Colvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Non-_0/_0 GenotypesRichard A. Colvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Grant Support
- Signaling Through Chemokine Receptor CXCR3National Institute Of Allergy And Infectious Diseases2001–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
